Congratulations on your pregnancy!
FirstGenderTest is the first company to develop and commercially introduce gender determination after pregnancy simply by testing urine since 1984. We have a unique technology to determine the gender of your baby from as early as you can do the pregnancy test up to approximately 20th week by testing maternal urine, sent to us by mail. This is the earliest and most accurate test in the world, currently holding an expected accuracy rate of approximately 95%. US and international patents are currently pending.
A Few Words About Us
We have discovered a new concept and are proud to add a new chapter in woman's reproductive physiology. We are the first one to prove and claim that women have equal role in gender formation. We offer two kinds of services:
Gender Planning Before Pregnancy, where we scientifically guide you in which cycle to conceive to get a baby of desired gender.
Gender Detection After Pregnancy, where we evaluate to determine the gender of the baby by testing a sample of the expecting mother's urine mailed to us, from as early as the 5th week of pregnancy (or just one day after missed menstrual due date) up to 20th week, with an expected accuracy of 95%.
Our Advantages
Are you planning a family? Perhaps there is a condition or trait that runs in your family, and is passed on to a certain gender. Or perhaps you have two sons and would like a daughter or vice versa. Whatever your reason, we welcome you to an exciting concept which stems from our observation that the female reproductive system also contributes to the gender of a baby!
Essentially, our hypothesis is that ovulation creates two types of physiological environments, one that creates an environment that is more suitable for the conception of a boy baby, and the other more suitable to a girl baby.
We were the first to initiate this work in 1984 and sent for publication to Medical Hypotheses in 1988 simply to make a record of it. At the time, we did not want to publish it as the methods were not perfect. We were amazed to find that between 2005 and 2008 there have been several publications in the medical field to substantiate our vision.Clinical and Management Team
Chief Scientist
Dr. Kuldeep Verma
In 1982, Dr. Verma discovered the difference in the urine of an expectant mother carrying a male fetus versus a female one. It took him two years to develop a procedure in collaboration with two hospitals, which provided urine samples from pregnant women who were soon to be due. The procedure enabled Dr. Verma to determine the gender of a fetus, with about 91% accuracy. Over time, with experience and testing of over around 17,000 samples, he found the accuracy to be highest during the first trimester, particularly from approximately the 5th through the 20th week of pregnancy.
Advisory Panel
Mark Brescia, MD
Dr. Brescia is a board certified Ob/Gyn physician in private practice in New Jersey (USA). Dr Brescia has been practicing for over 20 years. He has delivered over 5000 babies and has performed over 2500 gynecologic surgeries. The scope of his practice includes both low and high risk pregnancies as well as complete gynecologic care from teens to post menopause. Dr Brescia is the founder and senior partner of one of the busiest private practices in the New York, New Jersey metropolitan area.
"When I first learned about Urobiologics, I was very excited and had to incorporate this in my practice. In my experience, more then half of expecting parents are interested in knowing the sex of their baby. Urobiologics allows this to be done early, safely with sample collection in the privacy of their own home. This technology is new and exciting and I feel just the tip of the iceberg of what’s to come."
Michael Hynes, MD/MBA
Michael Hynes, MD/MBA: After obtaining a BS in Cellular Molecular Biology/BSE in Chemical Engineering from the University of Michigan, Michael worked for Merck&Co.'s vaccine engineering division developing techniques for upscaling from laboratory/pilot plant to large scale vaccine production before returning to the University of Michigan to finish his MS in Biochemical Engineering and obtain his Medical Degree.
While completing his residency in Radiology at Weil Cornell Medical College, he decided to pursue an MBA(University of Michigan Ross School of Business) and his interest in entrepreneurship, specifically start-up biotech oriented companies. He is now a practicing Board Certified Radiologist with experience helping 3 different biotech companies in their early stages of development.
Sumeet Verma, MD
A physician by training, he is an entrepreneur at heart. Just like his father, he brings tireless energy with a strong scientific foundation. After finishing his undergraduate in Public Health at University of North Carolina at Chapel Hill, he served in the Women, Infants, and Children Federal program to help meet the nutrition needs of low-income postpartum women.
Following medical school, he completed two different residencies and is licensed in two states.
Adam Wallach, MD
Dr. Wallach is a fully credentialed and licensed physician who currently works in North Carolina. Before medical school, he pursued his childhood dreams of helping in international charities and also volunteered as an AmeriCorps Program Coordinator.
Dr. Wallach obtained his Doctorate in Medicine from University of South Florida at Tampa before completing residency at Albert Einstein College of Medicine in New York. He’s currently licensed in multiple states and has presented his research in several academic conferences. Most recently, he authored a chapter in the textbook Functional Neuroimaging: A Clinical Approach. In his role as a Radiologist, he routinely interprets emergency first trimester ultrasound studies and has provided key advice in the strategic development of Urobiologics.